| Previous Close | 1.16 |
| Open | 1.17 |
| Bid | 0.83 x 100 |
| Ask | 1.30 x 1000 |
| Day's Range | 1.11 - 1.18 |
| 52 Week Range | 0.22 - 6.60 |
| Volume | 89,753 |
| Avg. Volume | 301,585 |
| Market Cap | 14.17M |
| Beta | 1.15 |
| PE Ratio (TTM) | -0.50 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Associated Press•10 days ago
Neuralstem reports 2Q loss
The Germantown, Maryland-based company said it had a loss of 39 cents per share. The biopharmaceutical company posted revenue of $2,500 in the period. Its adjusted revenue was $3,000. The company's shares ...
- MarketWatch•25 days ago
UPDATE: Neuralstem stock plummets 61% on news of mid-stage clinical trial miss
Neuralstem Inc. shares plummeted 61% in premarket trade Tuesday on news of a mid-stage clinical trial miss for its major depressive disorder drug. The drug, NSI-189, did not meet its primary endpoint of ...
- Capital Cube•2 months ago
ETFs with exposure to Neuralstem, Inc. : July 4, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Neuralstem, Inc. Here are 5 ETFs with the largest exposure to CUR-US. Comparing the performance and risk of Neuralstem, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
